Ebenezer Oloyede

679 total citations
34 papers, 380 citations indexed

About

Ebenezer Oloyede is a scholar working on Psychiatry and Mental health, Clinical Psychology and Philosophy. According to data from OpenAlex, Ebenezer Oloyede has authored 34 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Psychiatry and Mental health, 11 papers in Clinical Psychology and 10 papers in Philosophy. Recurrent topics in Ebenezer Oloyede's work include Schizophrenia research and treatment (28 papers), Mental Health and Psychiatry (10 papers) and Bipolar Disorder and Treatment (5 papers). Ebenezer Oloyede is often cited by papers focused on Schizophrenia research and treatment (28 papers), Mental Health and Psychiatry (10 papers) and Bipolar Disorder and Treatment (5 papers). Ebenezer Oloyede collaborates with scholars based in United Kingdom, United States and Israel. Ebenezer Oloyede's co-authors include David Taylor, Eromona Whiskey, Graham Blackman, Olubanké Dzahini, James H. MacCabe, Sukhwinder S. Shergill, Philip McGuire, Cecilia Casetta, Aviv Segev and Shubhra Mace and has published in prestigious journals such as SHILAP Revista de lepidopterología, The British Journal of Psychiatry and Neuropsychopharmacology.

In The Last Decade

Ebenezer Oloyede

28 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ebenezer Oloyede United Kingdom 13 324 84 74 64 59 34 380
Petru Ifteni Romania 11 325 1.0× 52 0.6× 94 1.3× 61 1.0× 73 1.2× 47 521
Graham Blackman United Kingdom 13 316 1.0× 52 0.6× 99 1.3× 54 0.8× 135 2.3× 38 563
D P O'Sullivan United Kingdom 5 374 1.2× 62 0.7× 62 0.8× 166 2.6× 64 1.1× 10 458
Lieberman Ja United States 8 225 0.7× 41 0.5× 46 0.6× 108 1.7× 43 0.7× 18 369
Ivo Caers Belgium 8 153 0.5× 31 0.4× 31 0.4× 46 0.7× 25 0.4× 10 327
J. Bollen Belgium 4 248 0.8× 66 0.8× 45 0.6× 97 1.5× 22 0.4× 4 399
Yuji Yada Japan 7 167 0.5× 33 0.4× 24 0.3× 21 0.3× 35 0.6× 19 233
Victoria Burtea Romania 11 194 0.6× 22 0.3× 45 0.6× 22 0.3× 18 0.3× 25 478
Valerie Powell Canada 10 217 0.7× 18 0.2× 24 0.3× 23 0.4× 49 0.8× 18 321
Onur N. Karayal United States 12 241 0.7× 19 0.2× 63 0.9× 22 0.3× 13 0.2× 24 452

Countries citing papers authored by Ebenezer Oloyede

Since Specialization
Citations

This map shows the geographic impact of Ebenezer Oloyede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebenezer Oloyede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebenezer Oloyede more than expected).

Fields of papers citing papers by Ebenezer Oloyede

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebenezer Oloyede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebenezer Oloyede. The network helps show where Ebenezer Oloyede may publish in the future.

Co-authorship network of co-authors of Ebenezer Oloyede

This figure shows the co-authorship network connecting the top 25 collaborators of Ebenezer Oloyede. A scholar is included among the top collaborators of Ebenezer Oloyede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebenezer Oloyede. Ebenezer Oloyede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, David, et al.. (2025). The Safety of 12‐Weekly Monitoring of Neutrophil Count in Long‐Term Clozapine Patients. Acta Psychiatrica Scandinavica. 152(3). 187–192. 3 indexed citations
2.
3.
Segev, Aviv, Risha Govind, Ebenezer Oloyede, et al.. (2024). Developing a validated methodology for identifying clozapine treatment periods in electronic health records. BMC Psychiatry. 24(1). 584–584.
4.
5.
Oloyede, Ebenezer, et al.. (2024). Cardiovascular outcomes of patients with atrial fibrillation and concomitant cardiac amyloidosis undergoing percutaneous catheter ablation. Current Problems in Cardiology. 50(3). 102953–102953.
6.
Oloyede, Ebenezer, et al.. (2023). The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia. BMC Psychiatry. 23(1). 413–413. 6 indexed citations
7.
Oloyede, Ebenezer, et al.. (2023). Clozapine augmentation with long‐acting antipsychotic injections: A case series and systematic review. Acta Psychiatrica Scandinavica. 148(6). 538–552.
8.
Oloyede, Ebenezer, Graham Blackman, Eleanor Harris, et al.. (2023). What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians. Schizophrenia. 9(1). 26–26. 15 indexed citations
9.
Oloyede, Ebenezer, Olubanké Dzahini, Siobhan Gee, et al.. (2023). Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study. The British Journal of Psychiatry. 223(2). 382–388. 13 indexed citations
10.
Egerton, Alice, J.F.W. Deakin, Richard Drake, et al.. (2022). Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration. Neuropsychopharmacology. 48(3). 567–575. 14 indexed citations
11.
Oloyede, Ebenezer, Eromona Whiskey, Cecilia Casetta, et al.. (2022). Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling study. The Lancet Psychiatry. 9(8). 636–644. 25 indexed citations
12.
Oloyede, Ebenezer, Graham Blackman, Eromona Whiskey, et al.. (2022). Clozapine haematological monitoring for neutropenia: a global perspective. Epidemiology and Psychiatric Sciences. 31. e83–e83. 36 indexed citations
13.
Segev, Aviv, Ehtesham Iqbal, Theresa A. McDonagh, et al.. (2021). Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy. The British Journal of Psychiatry. 219(6). 644–651. 19 indexed citations
14.
Oloyede, Ebenezer, Olubanké Dzahini, Aleksandar Mijović, et al.. (2021). Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals. BMC Psychiatry. 21(1). 502–502. 15 indexed citations
15.
Oloyede, Ebenezer, Bárbara Arroyo, Olubanké Dzahini, et al.. (2021). Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series. Journal of Psychopharmacology. 36(2). 223–231. 5 indexed citations
16.
Casetta, Cecilia, Ebenezer Oloyede, Eromona Whiskey, et al.. (2020). A retrospective study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis. The British Journal of Psychiatry. 217(3). 506–513. 11 indexed citations
17.
Casetta, Cecilia, Fiona Gaughran, Ebenezer Oloyede, et al.. (2020). Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study. BJPsych Open. 6(5). e82–e82. 7 indexed citations
18.
Oloyede, Ebenezer, Olubanké Dzahini, Eromona Whiskey, & David Taylor. (2019). Clozapine and Norclozapine Plasma Levels in Patients Switched Between Different Liquid Formulations. Therapeutic Drug Monitoring. 42(3). 491–496. 9 indexed citations
19.
Oloyede, Ebenezer, et al.. (2016). Continuous patient engagement in cardiovascular disease clinical comparative effectiveness research. Expert Review of Pharmacoeconomics & Outcomes Research. 16(2). 193–198. 7 indexed citations
20.
Oloyede, Ebenezer, et al.. (2014). Continuous patient engagement in comparative effectiveness research (CER): An application in cardiovascular disease (CVD). Value in Health. 17(3). A206–A206. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petru Ifteni Breakdown of academic impact, for papers by Graham Blackman Breakdown of academic impact, for papers by D P O'Sullivan Breakdown of academic impact, for papers by Lieberman Ja Breakdown of academic impact, for papers by Ivo Caers Breakdown of academic impact, for papers by J. Bollen Breakdown of academic impact, for papers by Yuji Yada Breakdown of academic impact, for papers by Victoria Burtea Breakdown of academic impact, for papers by Valerie Powell Breakdown of academic impact, for papers by Onur N. Karayal
Rankless by CCL
2026